Companies:
53,453
Total Market Cap:
174886977211507.50
Global Rank
#22461
Country Rank
#3537
Market Cap
172.48 M
Price
4.85
Change (%)
9.98%
Volume
13,287
Liminatus Pharma, Inc.'s latest marketcap:
172.48 M
As of 08/27/2026, Liminatus Pharma, Inc.'s market capitalization has reached $172.48 M. According to our data, Liminatus Pharma, Inc. is the 22461th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 172.48 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -12,523,251 |
| Shares Out | 26.01 M |
| EPS (ttm) | -18.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2026 |
Market Cap Chart
Data Updated: 08/27/2026
Liminatus Pharma, Inc.'s yearly market capitalization.
Liminatus Pharma, Inc. has seen its market value drop from $337.41 M to $172.48 M since 2021, representing a total decrease of 48.88% and an annual compound decline rate (CAGR) of 13.42%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/27/2026 | $172.48 M | -67.35% | 22461 |
| 12/31/2025 | $16.51 M | -79.39% | 15465 |
| 12/31/2024 | $80.1 M | 6.12% | 24763 |
| 12/27/2023 | $75.48 M | -78.38% | 24970 |
| 12/30/2022 | $349.14 M | 3.48% | 14592 |
| 12/31/2021 | $337.41 M | 15786 |
Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Frequently Asked Questions
-
What is Liminatus Pharma, Inc.'s (LIMN) current market cap?As of 08/27/2026, Liminatus Pharma, Inc. (including the parent company, if applicable) has an estimated market capitalization of $172.48 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Liminatus Pharma, Inc. (LIMN) rank globally by market cap?Liminatus Pharma, Inc. global market capitalization ranking is approximately 22461 as of 08/27/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.